Connect Biopharma Holdings Limited (CNTB)
Nasdaq: CNTB · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2020
Who owns Connect Biopharma Holdings Limited
As filed with the SECHolders of 5% or more
4
Panacea Innovation Limited holds 21.2% of Ordinary Shares, as its SCHEDULE 13D/A filed Apr 1, 2026 says.
Directors and officers
8
report now, of 8 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Panacea Innovation Limited
SCHEDULE 13D/A · filed Apr 1, 2026 · Ordinary Shares · 21.5% in Nov 26, 2025
Wubin Pan
SCHEDULE 13G · filed Apr 14, 2026 · Ordinary Shares, par value $0.000174 per share · 10.8% in Feb 17, 2026
Ikarian Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Ordinary Shares, par value $0.000174 per Share · 8.8% in Feb 17, 2026
Braden M Leonard
SCHEDULE 13G · filed Oct 6, 2026 · Ordinary Shares, par value $0.000174 per Share
Wei Zheng
SCHEDULE 13G/A · filed Aug 14, 2026 · Ordinary shares, par value $0.000174 · reported falling below 5%, from 6.2% in May 15, 2026
What CNTB reports owning in othersstakes of 5% or more, and other ties
6 subsidiaries in 4 countries, from the list filed with the 10-K filed Mar 31, 2026.
Insider tradesForm 4
0sales
2purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$4.4Mbought, in dollars
Open-market trades on Form 4 from Oct 1, 2025 to Oct 1, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 1, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 8 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Huang James | director | 0 | $0 | 0 | 2 | $4.4M |